Wordt geladen...
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
The development of several treatment options over the last 2 decades has led to a notable improvement in the survival of patients with multiple myeloma. Despite these advances, the disease remains incurable for most patients. Moreover, standard combinations of alkylating agents, immunomodulatory dru...
Bewaard in:
| Gepubliceerd in: | Ther Adv Hematol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8170343/ https://ncbi.nlm.nih.gov/pubmed/34104374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20406207211019622 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|